#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Interferon-Induced Protects Mice from Lethal VSV Neuropathogenesis


Interferon protects mice from vesicular stomatitis virus (VSV) infection and pathogenesis; however, it is not known which of the numerous interferon-stimulated genes (ISG) mediate the antiviral effect. A prominent family of ISGs is the interferon-induced with tetratricopeptide repeats (Ifit) genes comprising three members in mice, Ifit1/ISG56, Ifit2/ISG54 and Ifit3/ISG49. Intranasal infection with a low dose of VSV is not lethal to wild-type mice and all three Ifit genes are induced in the central nervous system of the infected mice. We tested their potential contributions to the observed protection of wild-type mice from VSV pathogenesis, by taking advantage of the newly generated knockout mice lacking either Ifit2 or Ifit1. We observed that in Ifit2 knockout (Ifit2−/−) mice, intranasal VSV infection was uniformly lethal and death was preceded by neurological signs, such as ataxia and hind limb paralysis. In contrast, wild-type and Ifit1−/− mice were highly protected and survived without developing such disease. However, when VSV was injected intracranially, virus replication and survival were not significantly different between wild-type and Ifit2−/− mice. When administered intranasally, VSV entered the central nervous system through the olfactory bulbs, where it replicated equivalently in wild-type and Ifit2−/− mice and induced interferon-β. However, as the infection spread to other regions of the brain, VSV titers rose several hundred folds higher in Ifit2−/− mice as compared to wild-type mice. This was not caused by a broadened cell tropism in the brains of Ifit2−/− mice, where VSV still replicated selectively in neurons. Surprisingly, this advantage for VSV replication in the brains of Ifit2−/− mice was not observed in other organs, such as lung and liver. Pathogenesis by another neurotropic RNA virus, encephalomyocarditis virus, was not enhanced in the brains of Ifit2−/− mice. Our study provides a clear demonstration of tissue-, virus- and ISG-specific antiviral action of interferon.


Vyšlo v časopise: Interferon-Induced Protects Mice from Lethal VSV Neuropathogenesis. PLoS Pathog 8(5): e32767. doi:10.1371/journal.ppat.1002712
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002712

Souhrn

Interferon protects mice from vesicular stomatitis virus (VSV) infection and pathogenesis; however, it is not known which of the numerous interferon-stimulated genes (ISG) mediate the antiviral effect. A prominent family of ISGs is the interferon-induced with tetratricopeptide repeats (Ifit) genes comprising three members in mice, Ifit1/ISG56, Ifit2/ISG54 and Ifit3/ISG49. Intranasal infection with a low dose of VSV is not lethal to wild-type mice and all three Ifit genes are induced in the central nervous system of the infected mice. We tested their potential contributions to the observed protection of wild-type mice from VSV pathogenesis, by taking advantage of the newly generated knockout mice lacking either Ifit2 or Ifit1. We observed that in Ifit2 knockout (Ifit2−/−) mice, intranasal VSV infection was uniformly lethal and death was preceded by neurological signs, such as ataxia and hind limb paralysis. In contrast, wild-type and Ifit1−/− mice were highly protected and survived without developing such disease. However, when VSV was injected intracranially, virus replication and survival were not significantly different between wild-type and Ifit2−/− mice. When administered intranasally, VSV entered the central nervous system through the olfactory bulbs, where it replicated equivalently in wild-type and Ifit2−/− mice and induced interferon-β. However, as the infection spread to other regions of the brain, VSV titers rose several hundred folds higher in Ifit2−/− mice as compared to wild-type mice. This was not caused by a broadened cell tropism in the brains of Ifit2−/− mice, where VSV still replicated selectively in neurons. Surprisingly, this advantage for VSV replication in the brains of Ifit2−/− mice was not observed in other organs, such as lung and liver. Pathogenesis by another neurotropic RNA virus, encephalomyocarditis virus, was not enhanced in the brains of Ifit2−/− mice. Our study provides a clear demonstration of tissue-, virus- and ISG-specific antiviral action of interferon.


Zdroje

1. DetjeCNMeyerTSchmidtHKreuzDRoseJK 2009 Local type I IFN receptor signaling protects against virus spread within the central nervous system. J Immunol 182 2297 2304

2. MullerUSteinhoffUReisLFHemmiSPavlovicJ 1994 Functional role of type I and type II interferons in antiviral defense. Science 264 1918 1921

3. HwangSYHertzogPJHollandKASumarsonoSHTymmsMJ 1995 A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. Proc Natl Acad Sci U S A 92 11284 11288

4. KatoHTakeuchiOSatoSYoneyamaMYamamotoM 2006 Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441 101 105

5. SatoMSuemoriHHataNAsagiriMOgasawaraK 2000 Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13 539 548

6. KumarHKawaiTKatoHSatoSTakahashiK 2006 Essential role of IPS-1 in innate immune responses against RNA viruses. J Exp Med 203 1795 1803

7. LoewendorfABenedictCA 2010 Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything. J Intern Med 267 483 501

8. AltfeldMFaddaLFrletaDBhardwajN 2011 DCs and NK cells: critical effectors in the immune response to HIV-1. Nat Rev Immunol 11 176 186

9. BenderSJWeissSR 2010 Pathogenesis of murine coronavirus in the central nervous system. J Neuroimmune Pharmacol 5 336 354

10. DurbinJEHackenmillerRSimonMCLevyDE 1996 Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84 443 450

11. MerazMAWhiteJMSheehanKCBachEARodigSJ 1996 Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84 431 442

12. DerSDZhouAWilliamsBRSilvermanRH 1998 Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A 95 15623 15628

13. SadlerAJWilliamsBR 2008 Interferon-inducible antiviral effectors. Nat Rev Immunol 8 559 568

14. SchogginsJWWilsonSJPanisMMurphyMYJonesCT 2011 A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472 481 485

15. FensterlVSenGC 2011 The ISG56/IFIT1 gene family. J Interferon Cytokine Res 31 71 78

16. TerenziFPalSSenGC 2005 Induction and mode of action of the viral stress-inducible murine proteins, P56 and P54. Virology 340 116 124

17. FensterlVWhiteCLYamashitaMSenGC 2008 Novel characteristics of the function and induction of murine p56 family proteins. J Virol 82 11045 11053

18. PichlmairALassnigCEberleCAGornaMWBaumannCL 2011 IFIT1 is an antiviral protein that recognizes 5′-triphosphate RNA. Nat Immunol 12 624 630

19. WacherCMullerMHoferMJGettsDRZabarasR 2007 Coordinated regulation and widespread cellular expression of interferon-stimulated genes (ISG) ISG-49, ISG-54, and ISG-56 in the central nervous system after infection with distinct viruses. J Virol 81 860 871

20. DaffisSSzretterKJSchriewerJLiJYounS 2010 2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 468 452 456

21. RubinsteinSFamillettiPCPestkaS 1981 Convenient assay for interferons. J Virol 37 755 758

22. LetchworthGJRodriguezLLDel C. BarreraJ 1999 Vesicular stomatitis. Vet J 157 239 260

23. PlakhovIVArlundEEAokiCReissCS 1995 The earliest events in vesicular stomatitis virus infection of the murine olfactory neuroepithelium and entry of the central nervous system. Virology 209 257 262

24. HuneycuttBSPlakhovIVShustermanZBartidoSMHuangA 1994 Distribution of vesicular stomatitis virus proteins in the brains of BALB/c mice following intranasal inoculation: an immunohistochemical analysis. Brain Res 635 81 95

25. BironCA 2001 Interferons alpha and beta as immune regulators–a new look. Immunity 14 661 664

26. HallerOKochsG 2011 Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity. J Interferon Cytokine Res 31 79 87

27. LenschowDJLaiCFrias-StaheliNGiannakopoulosNVLutzA 2007 IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci U S A 104 1371 1376

28. SaikiaPFensterlVSenGC 2010 The inhibitory action of P56 on select functions of E1 mediates interferon's effect on human papillomavirus DNA replication. J Virol 84 13036 13039

29. TerenziFSaikiaPSenGC 2008 Interferon-inducible protein, P56, inhibits HPV DNA replication by binding to the viral protein E1. EMBO J 27 3311 3321

30. WangCPflugheberJSumpterRJrSodoraDLHuiD 2003 Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication. J Virol 77 3898 3912

31. BelkowskiLSSenGC 1987 Inhibition of vesicular stomatitis viral mRNA synthesis by interferons. J Virol 61 653 660

32. ChristianAYBarnaMBiZReissCS 1996 Host immune response to vesicular stomatitis virus infection of the central nervous system in C57BL/6 mice. Viral Immunol 9 195 205

33. BiZBarnaMKomatsuTReissCS 1995 Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity. J Virol 69 6466 6472

34. BalachandranSRobertsPCBrownLETruongHPattnaikAK 2000 Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13 129 141

35. SchulzOPichlmairARehwinkelJRogersNCScheunerD 2010 Protein kinase R contributes to immunity against specific viruses by regulating interferon mRNA integrity. Cell Host Microbe 7 354 361

36. LeeHKLundJMRamanathanBMizushimaNIwasakiA 2007 Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 315 1398 1401

37. IannaconeMMosemanEATontiEBosurgiLJuntT 2010 Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus. Nature 465 1079 1083

38. TerenziFWhiteCPalSWilliamsBRSenGC 2007 Tissue-specific and inducer-specific differential induction of ISG56 and ISG54 in mice. J Virol 81 8656 8665

39. DaffisSSamuelMAKellerBCGaleMJrDiamondMS 2007 Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms. PLoS Pathog 3 e106

40. SimonIDPublicoverJRoseJK 2007 Replication and propagation of attenuated vesicular stomatitis virus vectors in vivo: vector spread correlates with induction of immune responses and persistence of genomic RNA. J Virol 81 2078 2082

41. VanderhallenHKoenenF 1997 Rapid diagnosis of encephalomyocarditis virus infections in pigs using a reverse transcription-polymerase chain reaction. J Virol Methods 66 83 89

42. KapilPAtkinsonRRamakrishnaCCuaDJBergmannCC 2009 Interleukin-12 (IL-12), but not IL-23, deficiency ameliorates viral encephalitis without affecting viral control. J Virol 83 5978 5986

43. PharesTWMarquesCPStohlmanSAHintonDRBergmannCC 2011 Factors supporting intrathecal humoral responses following viral encephalomyelitis. J Virol 85 2589 2598

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2012 Číslo 5
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Získaná hemofilie - Povědomí o nemoci a její diagnostika
nový kurz

Eozinofilní granulomatóza s polyangiitidou
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#